OMAHA, Neb., July 26, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University ...
ClearFlow, Inc., a medical device company based in Irvine, California, announced positive results from a clinical trial published in the peer-reviewed journal Innovations: Technology and Techniques in ...
OMAHA, Neb., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use ...
IRVINE, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of ...
PleuraFlow Active Clearance Technology (ACT; ClearFlow) is a chest drain that incorporates a tube clearance system. It comprises a silicone chest tube and the PleuraFlow clearance apparatus. The ...
Chest wall tumors are uncommon; surgical repair involves both resection of the tumor and reconstruction of the chest structures. Diagnosis of the tumor is performed to determine whether it is benign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results